196 related articles for article (PubMed ID: 10435158)
1. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
2. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
[TBL] [Abstract][Full Text] [Related]
5. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
Huang JS; Ho TJ; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 2001 Jan; 30(1):53-8. PubMed ID: 11140901
[TBL] [Abstract][Full Text] [Related]
6. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
7. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis.
Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K
Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein is positively correlated with p53 in human oral pre-malignant and malignant lesions and is associated with poor prognosis.
Ralhan R; Swain RK; Agarwal S; Kaur J; Nath N; Sarkar G; Mathur M; Shukla NK
Int J Cancer; 1999 Feb; 84(1):80-5. PubMed ID: 9988237
[TBL] [Abstract][Full Text] [Related]
10. pRb and p16 protein alterations in human oral tumorigenesis.
Pande P; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):396-403. PubMed ID: 9861348
[TBL] [Abstract][Full Text] [Related]
11. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 protein overexpression in betel- and tobacco-related oral oncogenesis.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1998 Aug; 79(4):370-5. PubMed ID: 9699529
[TBL] [Abstract][Full Text] [Related]
13. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
Ng IO; Lam KY; Ng M; Regezi JA
Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
[TBL] [Abstract][Full Text] [Related]
14. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
[TBL] [Abstract][Full Text] [Related]
16. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.
Baral R; Patnaik S; Das BR
Eur J Oral Sci; 1998 Oct; 106(5):907-13. PubMed ID: 9786319
[TBL] [Abstract][Full Text] [Related]
17. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
19. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Löhrs U
Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
[TBL] [Abstract][Full Text] [Related]
20. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]